Latest / UK Column Radio / The Abdominal Brain with Dr Sabine Hazan, Consultant Gastroenterologist – Part 1
Transcript
- 0:07Speaker 1: Hello, and welcome to another UK column interview. Well we
- 0:13Speaker 1: are what we eat and my name is Debbie Evans,
- 0:17Speaker 1: and for those of you that don't know me, I'm
- 0:19Speaker 1: a trained nurse and I'm joined today by our great
- 0:23Speaker 1: friend Cheryl Granger, who many of you will know, who's
- 0:26Speaker 1: an independent pharmaceutical training consultant. And I'm also joined by
- 0:31Speaker 1: Dr Sabine Hassan. And before I introduce doctor Hassan, I
- 0:36Speaker 1: just want to make a few points because doctor Hassan
- 0:39Speaker 1: is a gastro enterologist and she's based in the USA,
- 0:43Speaker 1: so she's got up very early to speak to us.
- 0:45Speaker 1: So thank you so much, and thank you also to
- 0:48Speaker 1: our producer Stephanie Sinclair for facilitating this interview as well.
- 0:53Speaker 1: But before I start, I want to say that the gut,
- 0:57Speaker 1: it's a huge subject, so we'd already decide I did that.
- 1:00Speaker 1: We we've really got such a big topic to discuss.
- 1:03Speaker 1: This is going to be the first interview of two
- 1:07Speaker 1: and we hear much research at the moment, don't we
- 1:10Speaker 1: of the brain and the heart and other systems in
- 1:14Speaker 1: the body. But how many of us really know that
- 1:17Speaker 1: we've got two brains? Yes, really two brains. We've got
- 1:21Speaker 1: an abdominal brain as well, and it's known as the
- 1:24Speaker 1: enteric nervous system. And many of you might think, yeah, actually,
- 1:29Speaker 1: you know what that gut feeling. I get that gut feeling.
- 1:33Speaker 1: I go with my gut feeling. You might be worried, sick,
- 1:37Speaker 1: you might have butterflies in your tummy, or you might
- 1:41Speaker 1: go with your gut. So your gut is connected to
- 1:45Speaker 1: your brain in your head, and it's incredibly important in
- 1:49Speaker 1: the biggest scheme of things because when we talk about
- 1:51Speaker 1: the immune system, where is the immune system? What is it? Well,
- 1:55Speaker 1: I think we're going to find out that a lot
- 1:57Speaker 1: of it is in the gut. We've got ten millions
- 2:00Speaker 1: of microbes in our gut that doctor Hasan is going
- 2:03Speaker 1: to talk to us about because she has a wealth
- 2:07Speaker 1: of experience in many areas that some of us might
- 2:11Speaker 1: not quite trust as much as we did, perhaps in
- 2:14Speaker 1: the old days, genomic sequencing, for example, laboratories, clinical trials.
- 2:22Speaker 1: Doctor Hasan is expert in all of this, and yet
- 2:26Speaker 1: she has literally sacrificed everything, literally everything, in order to
- 2:32Speaker 1: speak the truth. And we're just delighted to be able
- 2:35Speaker 1: to welcome to welcome you both. So, first of all, Cheryl,
- 2:40Speaker 1: welcome again. Thank you so much for agreeing to join us.
- 2:43Speaker 2: Thanks Debbie and Tello.
- 2:46Speaker 3: Sabine, it's lovely of you to join us today, and
- 2:49Speaker 3: we're looking forward immensely to what you have to tell us.
- 2:53Speaker 1: We absolutely are, and Sabine, let me bring you on
- 2:55Speaker 1: screen and say thank you so much for agreeing to
- 2:59Speaker 1: talk to us. If you could just give us a
- 3:00Speaker 1: little introduction as to who you are and why we're
- 3:03Speaker 1: here today.
- 3:04Speaker 4: I'm a gastr entrologist by trade that started doing clinical trials.
- 3:08Speaker 4: I actually got into GI doing my first year of
- 3:12Speaker 4: fellowship in research, and I kind of kept on with
- 3:16Speaker 4: research and clinical trials over the last three decades to
- 3:20Speaker 4: the point that when clinical trials became a capsule of
- 3:23Speaker 4: poop and we didn't really understand the microbiome, I kind
- 3:27Speaker 4: of stepped into the microbiome to understand it and doing
- 3:30Speaker 4: clinical research, and essentially here we are today thanks to
- 3:36Speaker 4: the microbiome telling the story and my genetic sequencing lab
- 3:40Speaker 4: for GENA biome has been spear adding a lot of
- 3:42Speaker 4: research and has published a lot of data on COVID,
- 3:46Speaker 4: A lot of it that was censored, but I think
- 3:48Speaker 4: it kind of demonstrated the corruption of science and research
- 3:52Speaker 4: right now and medicine really and why we're not advancing
- 3:56Speaker 4: or finding cures. There is a big problem going on here.
- 4:00Speaker 4: We are, That's what I'm doing here.
- 4:02Speaker 1: We are, indeed, and you've found out a lot of
- 4:05Speaker 1: solutions which we're going to come onto and protocols that
- 4:07Speaker 1: we're going to come on to. But I also want
- 4:09Speaker 1: to tell people of your book. Let's talk sh exclamation
- 4:15Speaker 1: mark T and that's really what it's all about and
- 4:19Speaker 1: what we're talking about today. But Sabine, before we talk
- 4:22Speaker 1: about what you've found out, which is fascinating when it
- 4:26Speaker 1: comes to in inverticomas COVID, the gut is massive. I
- 4:31Speaker 1: mean basically it goes from your teeth, doesn't it right
- 4:34Speaker 1: down to your a nurse, your rectum. So which part
- 4:38Speaker 1: of the guts? I know that we've got a diagram
- 4:40Speaker 1: which we're going to be showing our viewers of the
- 4:43Speaker 1: guts and it comes from it comes from your book, actually,
- 4:47Speaker 1: So which part of the gut will we be talking
- 4:50Speaker 1: about today?
- 4:51Speaker 4: I concentrate on feces in the colon. So that's the
- 4:55Speaker 4: part of the gut that we're going to talk about
- 4:57Speaker 4: is really the colon because that's what I analyz as
- 5:00Speaker 4: I analyzed the microbiome, which is really the feces. So
- 5:05Speaker 4: not a very sexy topic, but a very important topic.
- 5:09Speaker 4: And I think most people you know, tend to, you know,
- 5:14Speaker 4: notice things when it comes to that region and definitely
- 5:19Speaker 4: has been the number one complaint in the GI doctor's office.
- 5:22Speaker 4: So I think something that we, you know, forever we're
- 5:25Speaker 4: kind of like looking at the body the coll in,
- 5:28Speaker 4: but we never really looked at the feces themselves to
- 5:31Speaker 4: give us.
- 5:31Speaker 5: An idea on the disease. And this is the.
- 5:33Speaker 4: Path that I'm spearheading, that I'm looking at, and that
- 5:38Speaker 4: i'm you know, trying to find solutions essentially.
- 5:42Speaker 1: And solutions is exactly what you what you have found,
- 5:45Speaker 1: and we're fascinated to know about the gut microbiome. And
- 5:49Speaker 1: at this point, I know Cheryl is champing at the
- 5:52Speaker 1: bit literally to ask you some questions. So I'm going
- 5:55Speaker 1: to throw across to Cheryl to start off all the
- 5:58Speaker 1: questions about what you've found.
- 5:59Speaker 3: Out a lot of people, like you say, they don't
- 6:02Speaker 3: like talking about who you know, it's something you don't
- 6:04Speaker 3: talk about. They associate bacteria with illness. They don't expect that,
- 6:11Speaker 3: you know, because they have got a healthy diversity and
- 6:15Speaker 3: number of bacteria in the good that gives them health.
- 6:17Speaker 3: They don't get that at all. So I think we
- 6:20Speaker 3: need to go into that in more detail to explain
- 6:22Speaker 3: to people that it's a good thing to have the
- 6:25Speaker 3: right bacteria, the right type of bacteria in the right
- 6:28Speaker 3: place at the right time.
- 6:30Speaker 1: Yeah.
- 6:30Speaker 4: No, absolutely, And I think what we've learned from COVID COVID,
- 6:33Speaker 4: you know, was those were you know, there was a
- 6:37Speaker 4: time in my life anyways that was extremely scary, I
- 6:41Speaker 4: think for most people, and there was there were a
- 6:45Speaker 4: lot of unknowns, but I think there was also a
- 6:50Speaker 4: light at the end of the tunnel from COVID, and
- 6:53Speaker 4: the light is really understepped.
- 6:55Speaker 5: From me anyways.
- 6:56Speaker 4: It was taking the courage to treat people, and in
- 7:00Speaker 4: treating people, in achieving improvement of.
- 7:04Speaker 5: Survival of one person after another. It was really a way.
- 7:08Speaker 4: To understand the microbiome better because through treatment, I got
- 7:13Speaker 4: to see how a virus was in the stools, how
- 7:17Speaker 4: a virus was eradicated.
- 7:18Speaker 5: In the stools with treatment, how.
- 7:21Speaker 4: The power of the microbiome allows some people to survive
- 7:26Speaker 4: COVID and some people to not survive COVID, and.
- 7:28Speaker 5: I think that was, you know, that was the light
- 7:31Speaker 5: for me, and also a lot of a lot of interesting,
- 7:37Speaker 5: you know.
- 7:37Speaker 4: Facts on this for a lot of people, in my opinion,
- 7:41Speaker 4: because nobody really even thought to look at Wait a minute,
- 7:44Speaker 4: my poop can like support me, can help me? If
- 7:48Speaker 4: I have a solid poop, I can survive a virus.
- 7:51Speaker 4: How does that make sense?
- 7:52Speaker 5: Right?
- 7:53Speaker 4: I'm having an infection in the lung. To this day,
- 7:56Speaker 4: people are saying to me, well, you're a gas ter entrologist,
- 8:00Speaker 4: why are you even treating a long problem? And I
- 8:03Speaker 4: have to laugh because these people are complete, are completely
- 8:08Speaker 4: ignorant to the fact that the lungs are connected to
- 8:12Speaker 4: the colon, so you cannot fix the lungs without you know,
- 8:16Speaker 4: having to deal with the poland to begin with, and
- 8:19Speaker 4: having to deal with altering the microbes in the poland
- 8:22Speaker 4: to make sure that you know, half happens.
- 8:28Speaker 3: I think we've all been educated to think that we
- 8:31Speaker 3: go to a specialist for one particular problem and that's it.
- 8:34Speaker 3: And the specialists don't look at the whole body. They
- 8:37Speaker 3: look at just their specialism. And that has been a
- 8:40Speaker 3: downfall because obviously we need to talk about complete body health.
- 8:47Speaker 3: So tell us some more about this microbiome, tell us
- 8:50Speaker 3: about the functions of it, tell about the balance that
- 8:52Speaker 3: we have to have in it. And then obviously the
- 8:55Speaker 3: interconnections with immunity. Really, I think is the important bit
- 8:58Speaker 3: we need to know about.
- 9:00Speaker 4: Well, I think we're going to end up finding out
- 9:02Speaker 4: that immunity is in the gut. It starts in the gut,
- 9:06Speaker 4: It is in the gut. It is those microbes in
- 9:09Speaker 4: balance that's going to be the future. The future is
- 9:12Speaker 4: really looking at these microbes and saying, you've got too
- 9:15Speaker 4: much of these kinds that are not so good, and
- 9:18Speaker 4: you've got too little of these kinds that are good.
- 9:22Speaker 4: Maybe we need to up the good and drop the bag.
- 9:25Speaker 4: It's really, you know, the problem with this is that
- 9:28Speaker 4: it's not a necessarily a product. It's not necessarily a
- 9:35Speaker 4: consumer product, right, And it's really the art of medicine.
- 9:40Speaker 4: It's how do you fix someone that has an imbalanced microbiome?
- 9:44Speaker 2: Right?
- 9:45Speaker 4: And especially since the technology is really not there yet, right.
- 9:49Speaker 4: I mean, there's a lot of labs out there that
- 9:51Speaker 4: are doing that, but they're not really validated and they've
- 9:54Speaker 4: not really normalized their samples to even know, and also
- 9:58Speaker 4: there's no clinical data right on it. That's what we're doing.
- 10:02Speaker 4: That's what we're doing. We're looking at the clinical data.
- 10:05Speaker 4: We're looking at what does Alzheimer's look like, what does
- 10:07Speaker 4: Parkinson's look like?
- 10:09Speaker 5: What does autism look like? Right?
- 10:13Speaker 4: You know, so I think ultimately, you know, the microbiome
- 10:18Speaker 4: is a complex organ and it is an organ it
- 10:22Speaker 4: is where immunity starts. But at the same time, it's
- 10:26Speaker 4: the wild, wild West, and it's a new frontier that
- 10:29Speaker 4: we need to explore because there's so many things we
- 10:33Speaker 4: don't know.
- 10:33Speaker 5: And here's the other thing.
- 10:35Speaker 4: We've we've trusted animal studies to guide us in this field. However,
- 10:41Speaker 4: the animal studies do not reproduce human beings, and so
- 10:45Speaker 4: you know, that's another challenge that we have. And every
- 10:49Speaker 4: individual is different, so we can't even compare each other.
- 10:53Speaker 4: One person that may think that they're healthy compared to
- 10:56Speaker 4: another person is really you know, not necessarily only healthy, right,
- 11:01Speaker 4: So you know, they may have the same microbiome, but
- 11:04Speaker 4: the or not necessarily the same microbiome, but the same
- 11:08Speaker 4: relative abundance of microbes. One person could be halfy with
- 11:11Speaker 4: those microbes, and another person could be unhealthy so those
- 11:15Speaker 4: are the challenges that you know are in the field.
- 11:18Speaker 4: In my opinion, I think a.
- 11:20Speaker 3: Lot of people don't understand that we've got about five
- 11:22Speaker 3: pounds of body weight of bacteria living with us, and
- 11:27Speaker 3: we couldn't exist without them being there, and therefore it's
- 11:30Speaker 3: very important to look after this quite a large body
- 11:34Speaker 3: of microorganisms, and so we kind of outnumber the number
- 11:39Speaker 3: of bacterial cells we've got compared with our own body
- 11:43Speaker 3: cells about ten to one. So hopefully people know that
- 11:47Speaker 3: it's a big, big help. It's a big, big organist,
- 11:50Speaker 3: you've just called it. So we need to understand that
- 11:54Speaker 3: this is very important to us.
- 11:55Speaker 1: I do because I've read your book, Sabine, and it's
- 11:59Speaker 1: absolutely fascinating. It's really easy to read. It's for ordinary people.
- 12:05Speaker 1: There's there's no language that you won't understand. And what
- 12:08Speaker 1: I love about the way that you've written it, and
- 12:11Speaker 1: in other interviews you've said that actually you are a
- 12:14Speaker 1: gardener because the gut is like a big garden and
- 12:19Speaker 1: it tends it should have beautiful flowers in it and
- 12:21Speaker 1: it should be flourishing. But sadly, some of those fields
- 12:26Speaker 1: and gardens end up as weeds, which is why they
- 12:29Speaker 1: microbiome is so important. But when we when you first
- 12:34Speaker 1: heard of COVID, and I say that in inverted commas,
- 12:38Speaker 1: you were seeing patients as normal, right, and you were
- 12:41Speaker 1: they were coming into your surgery and they were poorly
- 12:44Speaker 1: and that's when you started to realize that there was
- 12:47Speaker 1: much more to this than met the eye. What were
- 12:50Speaker 1: your findings when you were seeing patients, because some of
- 12:52Speaker 1: them were coming in and they were pretty sick, weren't they.
- 12:56Speaker 4: Yeah, So, you know, I stepped in the front line
- 12:58Speaker 4: really not really thinking that carefully, right, I just you know,
- 13:03Speaker 4: you step into you know, you step into the frontline
- 13:07Speaker 4: as a physician, like you're stepping into a fire, you know,
- 13:10Speaker 4: and you're just trying to like throw water onto the
- 13:13Speaker 4: fire and helping the neighbors to remove, you know, to
- 13:17Speaker 4: stop houses from burning.
- 13:18Speaker 5: Really, that's what it was for me.
- 13:22Speaker 4: I just went in with complete faith, and I just
- 13:25Speaker 4: went in with, you know, I'm just going to do this,
- 13:28Speaker 4: and I'm going to do the research, and I'm going
- 13:31Speaker 4: to see what I see, and if I don't see anything,
- 13:33Speaker 4: then at least I'll have tried, Right, So I didn't
- 13:36Speaker 4: really think thoroughly of what I was going to find
- 13:40Speaker 4: and what was going to happen? I was, to be
- 13:43Speaker 4: quite honest, you know, I think the pandemic for me
- 13:47Speaker 4: was really witnessing miracles because when you see one person
- 13:51Speaker 4: that should have died and doesn't die on.
- 13:53Speaker 5: Your shift, you go, wait, what's going on here? Right?
- 13:56Speaker 4: And then you have another one and another one and
- 14:00Speaker 4: then they're hypoxic and there you know, oxygen is seventy
- 14:04Speaker 4: And then you realize.
- 14:05Speaker 5: Way you're giving the treatment that you believe is the
- 14:08Speaker 5: treatment that's improving the gut and killing the virus, and
- 14:12Speaker 5: somehow these people are surviving. How did that happen? Right?
- 14:17Speaker 4: And so when you look back, you know, so the
- 14:20Speaker 4: first instinct and I always said that, you know, from
- 14:23Speaker 4: the beginning during the pandemic, we should have just turned
- 14:25Speaker 4: off the fire. We should have like used as many hoses,
- 14:29Speaker 4: as many buckets and just turned off the fire. And
- 14:32Speaker 4: then said, okay, let's look back and see what has helped, right,
- 14:38Speaker 4: And so in retrospect, when you look back, and which
- 14:43Speaker 4: is what I did, you see the power of the microbiome.
- 14:46Speaker 4: You see the power of diffitobacteria. You see that when
- 14:49Speaker 4: you treat COVID, the one thing that you notice is
- 14:54Speaker 4: you have a virus in the stools, and then you
- 14:56Speaker 4: treat it and the virus disappears, and then you notice
- 15:00Speaker 4: the bacteria that you were You know that put those
- 15:03Speaker 4: people at risk of catching COVID to begin with, you know,
- 15:08Speaker 4: start growing back after treatment, you know, a long time
- 15:13Speaker 4: after treatment.
- 15:15Speaker 5: But you see that that tendencies, right, you see what happened,
- 15:20Speaker 5: you know with the treatment, what happened after the treatment?
- 15:24Speaker 5: Long term? You notice like what how do people go
- 15:28Speaker 5: to being long haulers?
- 15:30Speaker 4: You know long haulers. We published is loss of bifit
- 15:33Speaker 4: of bacteria. It's a microbound this biosis and I think
- 15:36Speaker 4: a lot of people have discovered that and have talked
- 15:39Speaker 4: about it. But also vaccine injury is loss of bifit
- 15:43Speaker 4: of bacteria. We showed that the vaccines affect the microviolement kills.
- 15:48Speaker 5: The bifit of bacteria.
- 15:49Speaker 4: Is that what's happening when people keep getting COVID covid
- 15:52Speaker 4: covid after vaccination because they've killed their vifit of bacteria
- 15:58Speaker 4: every time after you know, how many of your friends
- 16:01Speaker 4: have had the shot and said, you know, I noticed
- 16:04Speaker 4: that I got COVID a week after. Are they immuno
- 16:08Speaker 4: suppressed now? And therefore the virus comes in. You know,
- 16:12Speaker 4: there's so much to this that I think the pandemic
- 16:17Speaker 4: really you know, opened our eyes to that is important.
- 16:23Speaker 1: Sabine, you mentioned biffido bacteria. Could you explain to everybody
- 16:28Speaker 1: what because I know it's a really big it's a
- 16:31Speaker 1: big agenda for you and it's been groundbreaking what you've
- 16:35Speaker 1: found out, but can you tell people terms how important
- 16:40Speaker 1: it is.
- 16:42Speaker 5: So bifital bacteria is the bacteria.
- 16:45Speaker 4: That is in your probiotics.
- 16:48Speaker 5: It's that industry of I.
- 16:51Speaker 4: Think it's probably up to a trillion dollar industry of
- 16:54Speaker 4: probiotics by now. So that bacteria is very present in
- 17:00Speaker 4: newborns and it basically disappears with the aging process.
- 17:06Speaker 5: So essentially you're.
- 17:08Speaker 4: Born with a lot of microbes and you die of
- 17:11Speaker 4: a lot of good microbes and you die with very little.
- 17:14Speaker 4: So there was a thought that possibly this bacteria could
- 17:17Speaker 4: be you know, significant in health, right and thus the
- 17:23Speaker 4: billion dollar, trillion dollar industry of probiotics. When you look
- 17:28Speaker 4: at the microbiome of people that have disease, when you
- 17:31Speaker 4: look at chrome's disease, when you look at all sort
- 17:35Speaker 4: of collidis, when you look at invasive cancer line patients,
- 17:40Speaker 4: those people have zero bifito bacteria. So you have to
- 17:44Speaker 4: ask yourself, is the beginning of the disease the loss
- 17:49Speaker 4: of biffito bacteria? And is this why it's a chain reaction?
- 17:53Speaker 2: Right?
- 17:53Speaker 5: Everything in life is action leads to a reaction.
- 17:56Speaker 4: You know, you eat a hamburger that where the cow
- 18:00Speaker 4: is full of antibiotics and vaccinated galore, and then you
- 18:04Speaker 4: get sick with postertium the facill you know, that bacteria
- 18:09Speaker 4: starts secreting toxins, gives you diarrhea, and then eventually what
- 18:14Speaker 4: happens is you need an antibiotic to kill that bacteria,
- 18:18Speaker 4: but then you're killing off the whole microbiome. So a
- 18:22Speaker 4: microbe doesn't just sit on an island. A microbe, you know,
- 18:27Speaker 4: starts the chain reaction where action leads to a reaction.
- 18:32Speaker 4: So that's really what I think the bifido bacteria.
- 18:38Speaker 3: Can you say a little bit more about that, What
- 18:40Speaker 3: is that's achieving in the body when it's imbalanced and
- 18:43Speaker 3: it's actually you know, doing what it's supposed to do.
- 18:46Speaker 4: Well, I think we're at the beginning of all that, right.
- 18:49Speaker 4: I think we're just right now we're studying that it's
- 18:52Speaker 4: absent in certain diseases. We're studying how to increase it,
- 18:58Speaker 4: how to sustain it, how to because if you notice
- 19:02Speaker 4: a lot of because people would have a disease and
- 19:05Speaker 4: would take these probiotics and say, oh, well, you know
- 19:07Speaker 4: that would fix the disease.
- 19:08Speaker 5: Why is that not happening?
- 19:10Speaker 1: Right?
- 19:10Speaker 4: Why is it that people can take probiotics and not
- 19:14Speaker 4: fix their chrome's disease or their lime disease because the
- 19:18Speaker 4: probiotic doesn't either one, reach the colon. Two, it's probably
- 19:23Speaker 4: not real. In other words, there's no probiotic. There's no
- 19:27Speaker 4: bivito bacteria in that probiotic. Three, it's probably dead.
- 19:31Speaker 2: Right.
- 19:32Speaker 4: These microbes are very sensitive. So if you grow them
- 19:36Speaker 4: in a lab and then you put them in a
- 19:38Speaker 4: capsule and you expose them to air. Remember, you know
- 19:42Speaker 4: most of the microbiome lives in the colon, which is
- 19:45Speaker 4: not exposed to oxygen, right, So it's living in an
- 19:50Speaker 4: anaerobic format, right form, So what is that What are
- 19:55Speaker 4: you doing when you're exposing all that to the air, right,
- 19:58Speaker 4: all those microbes to the air.
- 20:00Speaker 5: So and then the other thing is how does it reach?
- 20:02Speaker 4: How does a probiotic reach from the stomach all the
- 20:04Speaker 4: way to the small vout to the sekum right. So
- 20:08Speaker 4: you know, it's it's a complex science. It's not one
- 20:11Speaker 4: that I can say, you know, I never put myself
- 20:14Speaker 4: in the rabbit hole of saying what it does what
- 20:17Speaker 4: it doesn't do. I just discuss my research that I've
- 20:21Speaker 4: done that validates others in the field, because unfortunately, the
- 20:27Speaker 4: microbiom is really about validation. It's about I did a research,
- 20:32Speaker 4: Now prove me wrong, and if somebody proves me right,
- 20:36Speaker 4: then that research is valid, verified and reproducible. So you'll notice,
- 20:41Speaker 4: like I talk a lot of things, and I do
- 20:44Speaker 4: a lot of you know, hypothesis, they're not.
- 20:48Speaker 5: Necessarily right until somebody else proves me right.
- 20:53Speaker 4: And that's in danger as a scientist and as a physician,
- 20:56Speaker 4: in my opinion, to say with certainty this is this
- 21:00Speaker 4: micro does and this and you should take this because
- 21:04Speaker 4: this way, because it improves this disease.
- 21:06Speaker 5: I think it's a mistake. You know, all we can
- 21:10Speaker 5: say in science and research is you know what I mean.
- 21:13Speaker 4: In my case with COVID, I you know, I've treated
- 21:16Speaker 4: thousands and I've lost no one. Okay, so that's a
- 21:20Speaker 4: step in the right direction to show well there's something
- 21:23Speaker 4: there right, maybe my protocols, maybe my way of treating
- 21:27Speaker 4: COVID was the way, and maybe we should kind of.
- 21:30Speaker 5: You know, reproduce those ways. Right. It's the same thing
- 21:34Speaker 5: with Alzheimer's.
- 21:35Speaker 4: I treated a case of Alzheimer's where the patient improved
- 21:38Speaker 4: his memory, and all I did was give him the
- 21:42Speaker 4: stools of his wife into his colon, and all of
- 21:45Speaker 4: a sudden he could remember his.
- 21:47Speaker 5: Daughter's date of birth.
- 21:48Speaker 4: So something happened when I changed the microboome of that
- 21:51Speaker 4: patient for that one case. Now, can I say fecal
- 21:56Speaker 4: transplant is the answer to Alzheimer's, No, absolutely not, because
- 22:00Speaker 4: this is an end of one. That end of one
- 22:03Speaker 4: needs to be reproduced, and then that end of one,
- 22:07Speaker 4: you know, may not be reproduced in all the Alzheimer's patients.
- 22:10Speaker 4: Maybe Alzheimer's is a microbiome disorder in some Maybe it's
- 22:15Speaker 4: a neurological disorder in others. Maybe it's the pathway between
- 22:19Speaker 4: the brain and the gut. Maybe it's the stem cells.
- 22:22Speaker 4: Maybe it's the you know, hype, you know, any any
- 22:26Speaker 4: of the components that are linked up with the brain,
- 22:30Speaker 4: you know, from the blood to the nerves, to the
- 22:32Speaker 4: lymphatics to everything. So you know, to get back to
- 22:36Speaker 4: you know, what was said before. You know, the body
- 22:38Speaker 4: is a complex organ that is all connected.
- 22:42Speaker 5: So I don't think. I think a lot of the.
- 22:44Speaker 4: Answers today you're going to have from me is probably
- 22:47Speaker 4: we don't know, and you know, we can guess we
- 22:50Speaker 4: don't know.
- 22:51Speaker 1: I think that's very fair, actually, and I think that's
- 22:53Speaker 1: what a hypothesis is about. And I know that you
- 22:56Speaker 1: have submitted hypothesis and they've been pretty much refuse. But
- 23:00Speaker 1: perhaps we can. We'll go on to that, and we'll
- 23:02Speaker 1: also go on, I think, to talk about fecal transplant
- 23:05Speaker 1: because I'm sure people's ears are pricked up and they thought,
- 23:07Speaker 1: what fecal transplants? So we will we will come back
- 23:10Speaker 1: and talk about that. But one thing that I did
- 23:12Speaker 1: want to say very quickly was you brought up the
- 23:14Speaker 1: subject there of probiotics, because now that we've told people
- 23:19Speaker 1: what Biffodo bacteria is, many people watching are going to
- 23:22Speaker 1: be saying, well, we want to increase hours. Well we'll
- 23:25Speaker 1: give it a go. What do we have? And of
- 23:27Speaker 1: course I know that you did your own little study,
- 23:30Speaker 1: didn't you on probiotics and you just went to your
- 23:33Speaker 1: grocery store and you analyzed what was in your grocery store.
- 23:38Speaker 1: And I think it's a very sobering reality for people
- 23:42Speaker 1: that are watching now that are maybe thinking about doing
- 23:45Speaker 1: their supermarket shop and they're going to pick up a
- 23:47Speaker 1: load of probiotics. What did you find in your study?
- 23:51Speaker 4: I had killed my bithelo bacteria and I was drinking
- 23:55Speaker 4: a leader of Kiefer every day, and I couldn't find
- 23:58Speaker 4: bifilo bacteria in my gut from that leader of Keifer.
- 24:01Speaker 4: So I tested the Keifer in my fridge and basically
- 24:05Speaker 4: noticed there was no bifito bacteria, even though it said
- 24:08Speaker 4: on the label Biffito bacteria. So I was curious because
- 24:12Speaker 4: here I am telling all my patients to drink Keifer.
- 24:15Speaker 4: Of course it's not going to improve their microbiome with
- 24:18Speaker 4: mine didn't even improve. So I went to my grocery
- 24:21Speaker 4: store in Malibu and picked up a whole bunch of
- 24:24Speaker 4: yogurts and a whole bunch of drinks that said biffitobacteria
- 24:29Speaker 4: in them. And then out of the drinks, out of
- 24:32Speaker 4: the twenty six drinks, only three of.
- 24:35Speaker 5: Them had bifit of bacteria.
- 24:37Speaker 4: And it was shocking because here I am telling patients, well,
- 24:43Speaker 4: go get Keifer and improve, go pick up a drink
- 24:47Speaker 4: that has bifito bacteria. It was shocking to find out
- 24:50Speaker 4: that actually so many drinks didn't have bifito bacteria. It
- 24:54Speaker 4: was also shocking to find out that out of the
- 24:58Speaker 4: drinks that didn't have Biffit bacteria, not only did the
- 25:03Speaker 4: drinks not have Bifito bacteria, but even the probiotics, let's
- 25:07Speaker 4: say Biflo bacteria, didn't have a Biflo bacteria in there.
- 25:11Speaker 4: Sixteen out of seventeen probiotics on the market have zero
- 25:15Speaker 4: Biffito bacteria. It's just a gimmick. They don't put Biffito
- 25:19Speaker 4: bacteria in there. So consumer beware because that's the problem.
- 25:25Speaker 4: You are thinking you're taking on some some probiotics or
- 25:31Speaker 4: some drinks that is improving your gut, and it's not
- 25:34Speaker 4: necessarily improving your gut.
- 25:36Speaker 1: Well, the next question, and I know that if our
- 25:39Speaker 1: audience could say this, they'll know that Cheryl and I
- 25:42Speaker 1: are both we've got our hands up asked because we
- 25:44Speaker 1: want to ask so many questions. And before I throw
- 25:47Speaker 1: to Cheryl for another question, can I just ask you
- 25:50Speaker 1: them for people that are watching. If we go to
- 25:53Speaker 1: our supermarkets and we're picking up probiotics that have no
- 25:57Speaker 1: biffodo bacteria in them, complete waste of mind. What can
- 26:01Speaker 1: we do to make sure that we are increasing our
- 26:05Speaker 1: bifodot bacteria. I mean, I've heard Saur Kraut mentioned, is
- 26:09Speaker 1: that what do you put in your diet, for example,
- 26:12Speaker 1: to increase your by bacteria.
- 26:14Speaker 5: So the first thing that I put in my diet
- 26:16Speaker 5: are vitamins.
- 26:17Speaker 4: So you know, don't underestimate the power of vitamin vitamin C,
- 26:21Speaker 4: Vitamin D increases the bifidobacteria, Zinc increases the firm acuities.
- 26:26Speaker 5: So you know, vitamin C, D and zinc.
- 26:28Speaker 4: That's why all my protocols throughout the pandemic had this formula.
- 26:34Speaker 5: You know, was very important.
- 26:36Speaker 4: It was really I cannot emphasize how important it was,
- 26:41Speaker 4: especially as that was the key vitamin that I gave
- 26:45Speaker 4: all my patients. So and the problem is even in
- 26:49Speaker 4: the vitamins, there's a lot of you know, I ended
- 26:52Speaker 4: up making my own vitamins during the pandemic because I
- 26:54Speaker 4: didn't trust what was out there, and they're just vitamins
- 26:57Speaker 4: for our research, you know what I mean. But unfortunately,
- 27:01Speaker 4: if you look at the majority of vitamins products out there,
- 27:05Speaker 4: there's a lot of fillers in them that actually make
- 27:09Speaker 4: them obsolete. They don't even help. So you could have
- 27:12Speaker 4: a person taking vitamin C, vitamin D zinc and it
- 27:15Speaker 4: didn't improve them. Then I would go back and say, well,
- 27:18Speaker 4: probably your vitamin had a lot of you know, stuff
- 27:21Speaker 4: in them that basically was not good you know, for
- 27:25Speaker 4: your microbiome. Okay, so that's one two, And this is
- 27:29Speaker 4: why you kind of like see a doctor do a research.
- 27:31Speaker 4: You know, there's a lot of doctors that I've trained
- 27:33Speaker 4: over the pandemic on the biome squad that I've you know,
- 27:37Speaker 4: helped out. So you know, anybody that wants to know
- 27:40Speaker 4: a doctor in the area, We've trained a lot of
- 27:42Speaker 4: doctors on how you know to treat et cetera.
- 27:46Speaker 5: Saying that the grocery stores.
- 27:49Speaker 4: Now know, or at least the companies that make these
- 27:53Speaker 4: probiotics and make these probiotic drinks now know that there
- 27:57Speaker 4: is someone watching, right, And what we've learned from the
- 28:01Speaker 4: pandemic is word of mouth pr So when something works,
- 28:07Speaker 4: it goes viral. Right like you saw ivermectin went viral
- 28:12Speaker 4: because it worked because people couldn't breathe. They were shorter
- 28:16Speaker 4: breath they took it and then all of a sudden
- 28:18Speaker 4: their chest opened up. What was the mechanism of that?
- 28:22Speaker 4: You know, by what why did this happen? Because actually
- 28:26Speaker 4: they increased their biffit of bacteria with ivermectin. But ivermectin
- 28:30Speaker 4: only does short term increase a bifit of bacteriity. There's
- 28:34Speaker 4: no data on it increasing bifito bacteria long term. So
- 28:38Speaker 4: how do you increase your bifit of bacteria when you've
- 28:41Speaker 4: lost it? You go back to a normal to your
- 28:44Speaker 4: diet that if you were healthy before, go back to
- 28:48Speaker 4: what you were eating. Increase fermented foods, vitamins, decrease the stress,
- 28:53Speaker 4: decrease the alco I actually tell all my patients one
- 28:57Speaker 4: glass of wine helps the.
- 28:59Speaker 5: Biffit of actor. However more than that doesn't.
- 29:03Speaker 6: But as you're building your bifito bacteria, it's probably not
- 29:07Speaker 6: a good idea to drink because you're trying to increase
- 29:11Speaker 6: those microps drugs.
- 29:13Speaker 4: You got to be careful what drugs you're taking. If
- 29:16Speaker 4: there's some drugs that you're taking that are suppressing the microbiome, foods,
- 29:21Speaker 4: if there's you know, meat that you're taking that's suppressing
- 29:24Speaker 4: your microbiome, you know everything. You have to be kind
- 29:28Speaker 4: of a detective, and it's not easy. It is not
- 29:31Speaker 4: easy to grow what you have killed. So the best advice.
- 29:36Speaker 5: Is to stop the killing. Why I was so adamant
- 29:40Speaker 5: and why I was so strong. You know why I was.
- 29:42Speaker 4: Such a voice during the pandemic with these vaccines is
- 29:46Speaker 4: because I was noticing they were killing the biffito bacteria
- 29:50Speaker 4: and one. And it's fine in those people that basically survived,
- 29:54Speaker 4: and you know, they have a resilient microbiome and they
- 29:56Speaker 4: bounce back and their bithito bacteria comes back after the vaccine,
- 30:01Speaker 4: but it's not okay for those people that do not
- 30:03Speaker 4: bounce back, where they constantly stay. And believe me, I'm
- 30:07Speaker 4: treating a lot of those patients and you know, it's
- 30:11Speaker 4: like a flatline. You're trying to resuscitate them. It's not
- 30:14Speaker 4: easy to necessitate what has been killed. So you got
- 30:18Speaker 4: to be careful and you got to stop the killing
- 30:20Speaker 4: to begin with, and you got to stop drugs that
- 30:23Speaker 4: are killing. You know, when you think about a drug
- 30:26Speaker 4: like hydroxychlork when that was like deemed you know, you know,
- 30:30Speaker 4: it was great for like people that were severe COVID zero,
- 30:34Speaker 4: bivito bacteria, people with arthritis and people that have already
- 30:38Speaker 4: killed their gut. You know, that's a great drug for
- 30:41Speaker 4: those people, but for people that are healthy, that's not
- 30:44Speaker 4: a great drug because it kills your microbiome.
- 30:47Speaker 5: So you know, same thing with antibiotics. Antibiotics are good
- 30:51Speaker 5: for someone with a.
- 30:52Speaker 4: Pneumonia that's in the hospital, that's dying, or an infection
- 30:57Speaker 4: that requires an antibiotic, but it's not necessarily good for
- 31:01Speaker 4: that young kid with a strong, resilient gut. Now you're
- 31:05Speaker 4: giving him an antibiotic and you're risking dropping his bit
- 31:09Speaker 4: of the bacteria and him not coming back up again.
- 31:12Speaker 5: That's really what the problem is.
- 31:15Speaker 3: I think the confusion for people is that we are
- 31:19Speaker 3: food isn't as good as it was, Our diet isn't
- 31:22Speaker 3: as good as it was. You know, you've been drinking
- 31:25Speaker 3: all that CAFA for all that time, and then obviously
- 31:28Speaker 3: it's not been doing you any good at all. Really,
- 31:30Speaker 3: it's not solving your problem.
- 31:33Speaker 5: So you're blind.
- 31:34Speaker 2: No, you don't know what you're taking.
- 31:37Speaker 5: No, you're absolutely blind.
- 31:39Speaker 4: And unfortunately that's what's happening, and it's the blind eating
- 31:42Speaker 4: the blind, right because here you're blind, and then another
- 31:47Speaker 4: person trying to sell their product. An influencer is selling
- 31:50Speaker 4: a product, and now they're in the limelight selling this.
- 31:54Speaker 5: Product and they don't even know it hurts them.
- 31:56Speaker 4: I mean, how many influencers have I treated that were
- 32:01Speaker 4: using their own products that they were, you know, raising
- 32:05Speaker 4: awareness on and actually that product ended up killing their
- 32:08Speaker 4: guts and then they killed the gods of others. So
- 32:12Speaker 4: I think, you know, we have I think people need
- 32:14Speaker 4: to be vigilant. I think we need to stop the
- 32:17Speaker 4: influence of healthcare. We really need to bring it back
- 32:21Speaker 4: to the doctor's office. We really need to have that
- 32:24Speaker 4: doctor patient relationship, and we need to educate our doctors
- 32:27Speaker 4: to understand the microbiome better, to step out of the guidelines.
- 32:32Speaker 5: We need to encourage our doctors to.
- 32:35Speaker 4: Step out of those guidelines, to be brave, to innovate.
- 32:39Speaker 4: You know, we've lost our medical feel And when you
- 32:42Speaker 4: lose your doctors, good luck when you're the patient, right,
- 32:46Speaker 4: because who are you going to go when you have
- 32:49Speaker 4: a doctor that's scared of giving.
- 32:51Speaker 5: You a safe drug.
- 32:52Speaker 4: So what we saw during the pandemic is a bunch
- 32:55Speaker 4: of scared doctors afraid to defy the government. As the
- 33:00Speaker 4: government is the doctor, right, So I mean at some
- 33:03Speaker 4: point we all got to keep our hats on to
- 33:06Speaker 4: realize who we are, what degrees we trained for. You know,
- 33:11Speaker 4: I would never you know, trust a plumber on you know,
- 33:16Speaker 4: on a colonoscopy just because he deals with the same
- 33:19Speaker 4: thing I deal boop, Right, So I think we have
- 33:23Speaker 4: to be you know, we the people need to stand
- 33:26Speaker 4: up for what's happening. Yes, you're right, we're blinded. But
- 33:30Speaker 4: here's the wake up call now that says we need
- 33:33Speaker 4: to demand of our agencies to have clean food. We
- 33:37Speaker 4: need to demand of our agencies to test these yogurts.
- 33:40Speaker 5: We need to.
- 33:41Speaker 4: Demand of our government to test these products. If it
- 33:44Speaker 4: says vital bacteria, it needs to have vivital bacteria. I'm
- 33:48Speaker 4: not the government. That's not my job. My job was
- 33:51Speaker 4: to do the research. I showcased something that's really important.
- 33:55Speaker 4: Sixteen out of seventeen probatists on the market have fake label.
- 34:03Speaker 4: Twenty three out of twenty six products with probotics on
- 34:06Speaker 4: the market have fake labels. They're fake. There's no bit
- 34:10Speaker 4: of a bacteria in there. It's up to the government.
- 34:13Speaker 4: It's up to the agencies to step it up and say,
- 34:16Speaker 4: you know, we're going to start testing the product. Stop
- 34:18Speaker 4: testing the paperwork. You know, I've been in the clinical
- 34:21Speaker 4: trap business for years and almost three decades or three decades,
- 34:27Speaker 4: and I got to tell you, you know, the one thing
- 34:30Speaker 4: the FDA always looks at is the paperwork. Stop looking
- 34:33Speaker 4: at the paperwork. Hire an independent lab to test the product.
- 34:36Speaker 4: You know, how do I know what's in that product?
- 34:39Speaker 4: The FDA needs to know they have the right formula.
- 34:43Speaker 4: They need to test that, and they need to retest
- 34:46Speaker 4: it what's in once.
- 34:47Speaker 5: It's in the market. Because here's the problem.
- 34:50Speaker 4: A lot of products do great in the research and
- 34:52Speaker 4: clinical trials and then they get to the market and
- 34:55Speaker 4: it's a substandard product and we're having complications. What happened
- 35:00Speaker 4: from the clinical trials to the market, the product change,
- 35:03Speaker 4: the transportation change, the temperature change of these products. You know,
- 35:09Speaker 4: is that why these products are no longer working? You
- 35:12Speaker 4: know what we saw with you know, we're stepping into
- 35:15Speaker 4: the microbiome world right now and fecal transplant, as we
- 35:20Speaker 4: said before, fecal transplant. When we do fecal transplant, as
- 35:22Speaker 4: gastrentrologists for SEEDEDIFF, a condition called seededf and we take
- 35:27Speaker 4: fresh poop from a family member or a sibling or
- 35:31Speaker 4: a stool bank that we trust, and it's fresh, that
- 35:36Speaker 4: patient has ninety two to ninety nine percent success in
- 35:40Speaker 4: resolving Postridium difficil bacteria that causes diarrhea. Okay, when we
- 35:47Speaker 4: saw the pharmaceutical product, even though they showed some great data, well,
- 35:51Speaker 4: guess what, the data on the frontline of medicine using
- 35:56Speaker 4: those products not as great as my fresh group. Something
- 35:59Speaker 4: is happening, something's changing. So you know, we need to
- 36:03Speaker 4: evaluate better, and we need to make sure that these
- 36:06Speaker 4: products that are out there are actually doing what they're
- 36:09Speaker 4: supposed to do in the AfD and needs to test
- 36:11Speaker 4: these products.
- 36:12Speaker 2: Obviously people turn to different things.
- 36:16Speaker 3: You're talking about Ibamactin is a filente product anyway, so
- 36:19Speaker 3: that perhaps is one of the advantages of it. But
- 36:23Speaker 3: you've got things like your vitamins. As long as you
- 36:25Speaker 3: get the right ones that are obviously made in the
- 36:28Speaker 3: right way, how.
- 36:29Speaker 5: Is that helping?
- 36:30Speaker 3: How is that helping the bifido bacteria? Does it make
- 36:33Speaker 3: it multiply more or what effect does it happen?
- 36:36Speaker 4: What we noticed is the vitamin C, for example, we
- 36:39Speaker 4: publish that paper increased bihilobacteria within twenty four hours, the
- 36:43Speaker 4: vironmin C increase the bifhilobacteria. So that's what we notice.
- 36:47Speaker 4: Now does it increase it long term? Do you have
- 36:50Speaker 4: to keep at it forever? Those are the studies we're
- 36:54Speaker 4: still doing and looking at all that. So we have about,
- 36:57Speaker 4: you know, sixteen hundred patients that have been on item
- 37:00Speaker 4: on a vitamin product that we were testing to see
- 37:03Speaker 4: what is that doing to the microbiome long term?
- 37:06Speaker 5: Short term? Does it increase?
- 37:09Speaker 4: You know, I've I have patients that I tested, you know,
- 37:13Speaker 4: basically that I tested before and after vaccination, before and
- 37:16Speaker 4: after vitamin C, and those patients I continue to.
- 37:19Speaker 5: Follow them and continue to follow their tools.
- 37:22Speaker 4: So it's interesting to see, you know, there's something to this,
- 37:26Speaker 4: but it's still in the beginning. You know, we're there's
- 37:29Speaker 4: only you know, there's only a few of us doctors
- 37:33Speaker 4: and scientists that progena biome. You know, we need to
- 37:36Speaker 4: we need funding, we need you know, all these tool
- 37:38Speaker 4: samples are extremely expensive. You know, I don't stop myself
- 37:43Speaker 4: from looking at things. So if somebody tells me, hey, cuman,
- 37:46Speaker 4: for example, cuman improves inflammation, and then I'll be the
- 37:50Speaker 4: first one to say, you know what, let me test
- 37:51Speaker 4: those tools before and after in fact, we're doing cuman.
- 37:55Speaker 4: You know, I'm the first one to test if somebody
- 37:58Speaker 4: tells me, hey, this this product is. I'm working on
- 38:01Speaker 4: a product right now with a gentleman which is going
- 38:04Speaker 4: to be a new drug with a gentleman from Switzerland,
- 38:09Speaker 4: and it's going to be a new product for als
- 38:12Speaker 4: and cancer.
- 38:13Speaker 5: And let me tell you, it's.
- 38:15Speaker 4: Unbelievable what it's doing to the befito bacteria. So I'm
- 38:18Speaker 4: very excited for this guy about this product because when
- 38:22Speaker 4: it comes out, when it starts in the clinical trials,
- 38:24Speaker 4: we'll have the data not only about the clinical trial
- 38:27Speaker 4: the efficacy because right now, actually that product is in
- 38:29Speaker 4: a phase three clinical trial. So there are pharmaceutical companies
- 38:33Speaker 4: that are doing it the right way. They're totally legit,
- 38:36Speaker 4: and they're trying to help patients along the way and
- 38:39Speaker 4: they're righteous, you know. And usually those are companies that
- 38:43Speaker 4: are owned by physicians because.
- 38:45Speaker 5: They have a code of ethics for the most part.
- 38:50Speaker 4: And so you know, this compound was in a phase
- 38:53Speaker 4: three trial and what we noticed is it actually.
- 38:57Speaker 5: Increases the befito of bacteria by twenty percent.
- 38:59Speaker 4: So this is something that I can put, you know,
- 39:02Speaker 4: my company behind because I say, hey, you know what,
- 39:05Speaker 4: I tested this product, then it does what it's supposed
- 39:08Speaker 4: to do. Listen, there's a lot of products in the
- 39:10Speaker 4: market that actually increase the birth of the bactuity, none of
- 39:13Speaker 4: them that I can say on this podcast or say publicly,
- 39:17Speaker 4: because unfortunately it's not my job. Right the data needs
- 39:21Speaker 4: to be written first before it gets talked about, and
- 39:25Speaker 4: so that's that's the way it's always been and that's
- 39:29Speaker 4: the way it will be.
- 39:30Speaker 1: This is such a big subject because the gut is
- 39:33Speaker 1: a very big organ and we're not talking enough about
- 39:37Speaker 1: what we're eating and where it's going. Because what goes
- 39:41Speaker 1: in has got to come out. So we're going to
- 39:43Speaker 1: be talking very much about your experiences with COVID and
- 39:48Speaker 1: your protocols and your work in the Senate in part
- 39:52Speaker 1: two of this interview, and just before we finish part one,
- 39:57Speaker 1: and I did warn everybody this is a big, big subject.
- 40:01Speaker 1: Before we go to your last word on this particular
- 40:05Speaker 1: part of our interview, I just want to come back
- 40:08Speaker 1: a little bit on the fecal transplants because people will
- 40:11Speaker 1: be thinking, really really, doctor hasan you're taking fresh poop
- 40:17Speaker 1: from a family member in a like in a test
- 40:22Speaker 1: tube or in a syringe, and you're literally implanting it
- 40:27Speaker 1: in somebody else's colon in order to grow back that
- 40:31Speaker 1: beautiful garden of microbes. And I get that, And I
- 40:36Speaker 1: think my question will be, after the injection with mRNA
- 40:41Speaker 1: and spike proteins, etc. How would that affect? Because I
- 40:46Speaker 1: know that people are very wary about blood transfusions and
- 40:50Speaker 1: about whether things are being body products, bodily fluids are
- 40:53Speaker 1: being checked. Equally, I would say, will people be worrying
- 40:57Speaker 1: now if they want to go down the fecal tr
- 41:00Speaker 1: Trump's plant routes as to how safe that is in
- 41:03Speaker 1: twenty twenty four.
- 41:05Speaker 5: I don't know.
- 41:06Speaker 4: Those are the This is one of those things that
- 41:08Speaker 4: I don't know. I don't know if the mRNA stays
- 41:11Speaker 4: in the stools. I don't know if the mRNA stays
- 41:14Speaker 4: alive for that long.
- 41:16Speaker 5: I don't know. You know that those are That's a
- 41:22Speaker 5: good question. We don't know.
- 41:23Speaker 4: I think we will know from like these products that
- 41:26Speaker 4: are on the market already and their success rate and seeing, well,
- 41:30Speaker 4: why aren't they as successful as before the pandemic? You
- 41:34Speaker 4: know what is changed. Right, If eco transplant, you know,
- 41:39Speaker 4: doesn't work as well using a family member or fresh donor,
- 41:44Speaker 4: then one wonders, maybe there is something in the stools.
- 41:48Speaker 4: We are developing a stool asset to look for spike protein.
- 41:52Speaker 4: I think that's important.
- 41:54Speaker 5: We are, you know, and here's the thing.
- 41:57Speaker 4: You know, when we process these tools, you know, I
- 42:00Speaker 4: mean some of us use the lab you know from
- 42:03Speaker 4: University of Minnesota or a fecal bank that's available for
- 42:07Speaker 4: doctors and also and those are processed very well. You know,
- 42:12Speaker 4: my lab, we do families and we have patients you know,
- 42:17Speaker 4: that want to know who their donors are.
- 42:20Speaker 5: So we do very extensive testing. We test for COVID
- 42:23Speaker 5: in the stools.
- 42:24Speaker 4: That's why we're developing this spike protein assay to look
- 42:28Speaker 4: for spike in the stools before we transplant, because we
- 42:31Speaker 4: want to make sure we transplant a quality microbiome and
- 42:36Speaker 4: not just poop, right, because otherwise anybody could do that
- 42:39Speaker 4: in their kitchen counter. But if you do that in
- 42:41Speaker 4: your kitchen counter and you're implanting a micro dot's toxic,
- 42:45Speaker 4: you're pretty much could kill yourself, right, So you know,
- 42:49Speaker 4: there is a process of sterility within the poop, right.
- 42:53Speaker 4: I mean, it's not just like we're taking fresh poop
- 42:55Speaker 4: and we're just planting it. It doesn't work like that,
- 43:00Speaker 4: although we do make it seem like we're just taking stools,
- 43:03Speaker 4: put it in a blender, you know, like the south
- 43:05Speaker 4: Park episode that you all saw where you know, they
- 43:08Speaker 4: take the poop, they put it in a blender, blend it
- 43:11Speaker 4: and put it in a pone. You know, it does
- 43:13Speaker 4: appear like this is how we do it, but you
- 43:15Speaker 4: know there is more to that, and it is kind
- 43:19Speaker 4: of a you know, semi sterile procedure.
- 43:21Speaker 5: And I always joke because you.
- 43:23Speaker 4: Know, my staff, in my lab, everything is sterile, you
- 43:26Speaker 4: know when we do these transplantations.
- 43:29Speaker 5: And I always joke because I go, you realize we're
- 43:32Speaker 5: sterile when we're dealing with poop, right, But you know,
- 43:37Speaker 5: here it is. Here's the thing. It is an organ.
- 43:40Speaker 5: It's an organ.
- 43:41Speaker 4: You have to start thinking of it as an organ.
- 43:43Speaker 4: It's like a kidney, it's like a heart. Why wouldn't
- 43:46Speaker 4: you do a transplant if you have a gut that
- 43:49Speaker 4: if you have a microbound that's out of whack completely,
- 43:53Speaker 4: and you have a disease, why wouldn't you take a
- 43:56Speaker 4: healthy organ and implant it into human We actually put
- 44:03Speaker 4: are publishing data that's going to be coming about what's
- 44:07Speaker 4: in the poop, so you know, it's not only poop
- 44:11Speaker 4: that you're transplanting. So it's important for people to understand.
- 44:15Speaker 4: You know, you've got blood vessel, you've got blood in
- 44:18Speaker 4: the stools, you know, so you've got to do the
- 44:20Speaker 4: proper workup to make sure that it's the bacteria that
- 44:24Speaker 4: you're transplanting and not the poop. Right, So you know,
- 44:29Speaker 4: that's an important concept that when we talk about and
- 44:31Speaker 4: I think.
- 44:32Speaker 5: It was named in a way. It was called fecal transplant,
- 44:36Speaker 5: but I think it should have been you know, and
- 44:38Speaker 5: doctor Alex Caruz says that it should have been called,
- 44:42Speaker 5: you know, microbiota transplant because it is the microbiome that
- 44:45Speaker 5: we're transplanting.
- 44:46Speaker 2: Not the poop.
- 44:48Speaker 4: So you know, the poop is with the fibers and
- 44:51Speaker 4: the food and the blood and all that.
- 44:53Speaker 5: So but we just are taking these tools.
- 44:56Speaker 1: Well, I want to thank you for that because I
- 44:59Speaker 1: know if you you're in the UK, our government is
- 45:02Speaker 1: very keen to have our pooh. Most of the population
- 45:07Speaker 1: have been sent bowel tests and they're very very keen
- 45:11Speaker 1: to have that, so perhaps we can talk about that
- 45:14Speaker 1: in part two. But do to you for your word,
- 45:16Speaker 1: and I am super super grateful for your time. I
- 45:20Speaker 1: just want to give Cheryl the opportunity to come back
- 45:23Speaker 1: before we go to your last word, Cheryl, is there
- 45:25Speaker 1: anything you would like to add to this before we
- 45:28Speaker 1: end this interview and head for part two.
- 45:32Speaker 3: I just hope that what we've said so far as
- 45:35Speaker 3: welcome people look to how important your gutzah and in
- 45:39Speaker 3: particular you call on and in particular the microbioon within it,
- 45:44Speaker 3: and whatever they learn about themselves to try and improve
- 45:47Speaker 3: that they should do it because it's a main part
- 45:52Speaker 3: of continuing with health. So hopefully we've got that message across.
- 45:58Speaker 1: Yeah, and thank you, Thank you Cheryl for joining us.
- 46:01Speaker 1: And if you like what the UK column are doing,
- 46:04Speaker 1: and if you found this interview helpful, please share our
- 46:08Speaker 1: work and please share doctor Hassan's work. All of the
- 46:12Speaker 1: details of where to find her and details of her
- 46:15Speaker 1: book will be in the article that will be directly
- 46:18Speaker 1: beneath this interview. So on that note, Dr Hassan, for
- 46:22Speaker 1: the end of part one, I would like to thank
- 46:25Speaker 1: you enormously for joining us and to give you the
- 46:28Speaker 1: last word.
- 46:29Speaker 5: Thank you again, well, thank you, thank you for having me.
- 46:33Speaker 5: And I think the.
- 46:33Speaker 4: Last world is the last word. That would be hope
- 46:39Speaker 4: for peace and microbiome and save the Biff. That's my mission,
- 46:47Speaker 4: that's my path for increase awareness on beffelobacteria and make
- 46:53Speaker 4: sure that we still have it in this planet.